Cofactor Genomics

📍 San Francisco, United States🗓 Founded 2015👥 13 employees💰 Last funded 2019
Biotechnology🌐 cofactorgenomics.com
Website LinkedIn
Cofactor Genomics’s mission is to create diagnostics that have the ability to predict the patients that can benefit from immunotherapies. Using more insightful multidimensional biomarkers created with RNA and machine learning, Cofactor’s diagnostics offer greater predictive power than any current test. Instead of searching for isolated, single-analyte biomarkers or DNA mutations, Cofactor’s products create multidimensional biomarkers that better capture the complex immune response at the site of a tumor. Cofactor Genomics empowers clinicians to be better informed while making treatment decisions to improve patient outcomes.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Cofactor Genomics?
Cofactor Genomics has 1 investors on record on gritt.io, 1 mid-stage.
When did Cofactor Genomics last raise funding?
The most recent investment in Cofactor Genomics recorded on gritt.io was in 2019.
When was Cofactor Genomics founded?
Cofactor Genomics was founded in 2015.
What industry is Cofactor Genomics in?
Cofactor Genomics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Cofactor Genomics based?
Cofactor Genomics is headquartered in San Francisco, United States.